Healthcare Triangle, Inc. (HCTI) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.00
↓-100% vs avg
5yr avg: 1.46
30Y Low0.0·High3.3
ROE
↓
-392.4%
↑-65% vs avg
5yr avg: -238.4%
30Y Low-392%·High75%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low0.4·High0.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
HCTI Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Healthcare Triangle, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1300 | $23491 | $5M | $11M | $7M | $53M | — | — |
| Enterprise Value | $3M | $3M | $8M | $14M | $8M | $55M | — | — |
| P/E Ratio → | -0.00 | — | — | — | — | — | — | — |
| P/S Ratio | 0.00 | 0.00 | 0.44 | 0.34 | 0.14 | 1.50 | — | — |
| P/B Ratio | 0.00 | 0.00 | — | — | 1.09 | 3.28 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
HCTI EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.23 | 0.67 | 0.42 | 0.17 | 1.55 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
HCTI Profitability
Margins and return-on-capital ratios measuring operating efficiency
Healthcare Triangle, Inc. earns an operating margin of -70.5%. Operating margins have compressed from -23.2% to -70.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -392.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.6% | 13.6% | 24.7% | 20.4% | 24.6% | 29.8% | 24.8% | 17.7% |
| Operating Margin | -70.5% | -70.5% | -40.6% | -23.2% | -35.6% | -15.2% | 3.8% | 5.8% |
| Net Profit Margin | -68.2% | -68.2% | -51.0% | -26.2% | -31.3% | -16.9% | 7.5% | 4.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -392.4% | -392.4% | — | -373.7% | -129.5% | -58.1% | 74.7% | 59.3% |
| ROA | -76.7% | -76.7% | -135.4% | -86.3% | -75.8% | -33.3% | 24.3% | 14.2% |
| ROIC | -138.9% | -138.9% | — | -133.5% | -97.1% | -37.4% | 37.7% | 125.2% |
| ROCE | -405.3% | -405.3% | — | -286.5% | -130.4% | -47.2% | 36.9% | 81.3% |
HCTI Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $3M ($11M total debt minus $8M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.08 | 1.08 | — | — | 0.44 | 0.21 | 0.17 | — |
| Debt / EBITDA | — | — | — | — | — | — | 0.38 | — |
| Net Debt / Equity | — | 0.31 | — | — | 0.22 | 0.10 | -0.15 | -0.49 |
| Net Debt / EBITDA | — | — | — | — | — | — | -0.33 | -0.40 |
| Debt / FCF | — | — | — | — | — | — | — | -0.25 |
| Interest Coverage | -17.26 | -17.26 | -3.91 | -7.94 | -64.34 | -9.45 | 14.96 | 31.75 |
HCTI Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.03x means Healthcare Triangle, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.69x to 1.03x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.03 | 1.03 | 0.21 | 0.69 | 1.22 | 1.89 | 1.18 | 0.85 |
| Quick Ratio | 1.03 | 1.03 | 0.21 | 0.69 | 1.22 | 1.89 | 1.18 | 0.85 |
| Cash Ratio | 0.60 | 0.60 | 0.00 | 0.15 | 0.20 | 0.28 | 0.21 | 0.16 |
| Asset Turnover | — | 0.61 | 5.96 | 4.84 | 3.46 | 1.43 | 2.82 | 3.48 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 54.39 | 34.64 | 39.52 | 46.65 | 100.09 | 74.50 | 52.97 |
HCTI Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Healthcare Triangle, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 2.1% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 2.1% | 0.0% | — | — |
| Shares Outstanding | — | $619 | $353 | $280 | $248 | $197 | $236 | $236 |
Peer Comparison
Compare HCTI with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 HCTIYou | $1300 | -0.0 | — | — | 13.6% | -70.5% | -392.4% | -138.9% | — |
 HIMS | $7B | 65.8 | 52.5 | 99.6 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 HCAT | $127M | -0.7 | 17.2 | — | 33.5% | -11.6% | -58.3% | -6.1% | 11.9 |
 MTEX | $10M | -0.7 | 7.1 | — | 74.9% | -0.4% | -897.3% | — | 4.5 |
 VEEV | $25B | 28.2 | 19.7 | 17.9 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 INVA | $2B | 6.9 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 DOCS | $4B | 20.5 | 16.5 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 MSFT | $2.7T | 26.9 | 17.3 | 38.1 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 |
 AMZN | $2.5T | 32.5 | 17.6 | 325.3 | 50.3% | 11.2% | 22.3% | 14.7% | 1.0 |
 GOOGL | $4.2T | 32.3 | 28.3 | 57.7 | 59.7% | 32.1% | 35.7% | 25.1% | 0.4 |
 ORCL | $504B | 30.0 | 21.9 | — | 65.2% | 30.8% | 53.4% | 11.0% | 5.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
HCTI — Frequently Asked Questions
Quick answers to the most common questions about buying HCTI stock.
What is Healthcare Triangle, Inc.'s P/E ratio?
Healthcare Triangle, Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
What is Healthcare Triangle, Inc.'s ROE?
Healthcare Triangle, Inc.'s return on equity (ROE) is -392.4%. The historical average is -136.6%.
Is HCTI stock overvalued?
Based on historical data, Healthcare Triangle, Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Healthcare Triangle, Inc.'s profit margins?
Healthcare Triangle, Inc. has 13.6% gross margin and -70.5% operating margin.